New Bolton Center Presents Lecture on Metabolic Disease in Horses
Edited Press Release
January 3, 2013
The lecture will focus on diagnosis and management of metabolic disorders, such as EMS and PPID.
Information on pituitary pars intermedia dysfunction (PPID), also known as Cushing’s Disease in horses.
The lecture will focus on diagnosis and management of metabolic disorders, such as EMS and PPID.
Endocrinology researchers met to discuss equine metabolic syndrome (EMS) and equine Cushing’s disease (PPID).
The recording of TheHorse.com’s Ask the Vet LIVE event on equine Cushing’s disease (PPID) from Sept. 18, 2012.
Pituitary Pars Intermedia Dysfunction (PPID, or equine Cushing’s disease) is one of the most common endocrine disorders in horses and can cause secondary issues, including laminitis. But, proper supportive care can offer comfort to many PPID horses.
During this live event, our experts will answer your questions about caring for the Cushingoid horse.
Certain feeding strategies can help your horse weather equine Cushing’s disease.
Test for the common endocrine disorders Cushing’s disease and equine metabolic syndrome and treat accordingly.
The change comes several months after the FDA approved a pergolide mesylate tablet for use in horses.
A new FDA-approved Pergolide product offers options in the management of clinical signs associated with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease.
The objective of the survey is to determine the prevalence of Cushing’s disease worldwide.
Season variations in ACTH levels are found in some geographic areas, while no changes take place in others.
“Cushing’s Disease and Equine Metabolic Syndrome” was presented by three authorities on the topics.
Three veterinarians discuss the challenges of properly diagnosing and treating/managing horses afflicted with equine Cushing’s disease, equine metabolic syndrome, and associated laminitis.
Endocrinopathic laminitis might be more common in horses affected by endocrine disease than once believed.
The newly approved medication is the first and only FDA-approved product for managing PPID in horses.
The Arabian Horse Foundation released summaries of the research projects the organization funded in 2011.
Stay on top of the most recent Horse Health news with
